AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitaglo M Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaglo M Tablet

Metformin and glimepiride, combined in Sitaglo M Tablets, effectively manage elevated blood glucose in type 2 diabetes patients. This dual action mitigates serious diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Sitaglo M may be prescribed independently or alongside other antidiabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Continued commitment to the prescribed diet and exercise plan is crucial for diabetes management, as lifestyle significantly influences blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially with concurrent insulin or sulfonylurea use; patients must be prepared to manage this complication. This medication isn't universally suitable. Prior to initiation, disclose any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption to your doctor. Pregnant or lactating individuals require medical consultation before use. Inform your physician of all medications being taken to ensure safety, as drug interactions are possible. Alcohol should be minimized due to its hypoglycemic effects. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of Sitaglo M Tablet

Managing Type 2 Diabetes

Major Benefits of Sitaglo M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaglo M Tablet with a meal.

Common Side effects of Sitaglo M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglo M Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaglo M Tablet with a meal.

How Sitaglo M Tablet works:

Sitagliptin and metformin, the components of Sitaglo M Tablet, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces glucose production in the liver, slows intestinal glucose absorption, and augments insulin sensitivity. This combined action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitaglo M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaglo M Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Sitaglo M Tablet use may pose a risk. Available data in humans indicate potential transfer to breast milk, potentially causing infant harm.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitaglo M Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitaglo M Tablet use. Regular monitoring of kidney function is recommended during treatment; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver disease should avoid Sitaglo M Tablets due to the high risk of adverse effects. Medical advice is recommended.

What if you forget to take Sitaglo M Tablet :

Should you forget to take a Sitaglo M Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglo M Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Sitaglo M Tablet

Sitagliptin and Metformin, combined as Sitaglo M Tablet, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and physical activity. Metformin reduces liver glucose production and boosts insulin sensitivity. Sitagliptin works by suppressing DPP4 enzyme activity, thus promoting pancreatic insulin release. This formulation is unsuitable for individuals under 18.
Prolonged Sitaglo M Tablet use can indeed lead to vitamin B12 deficiency by disrupting its gastric absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications. Symptoms can include paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures proposed by some studies include annual supplemental vitamin B12 intake.
Sitaglo M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Sitaglo M Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. This medication should not be administered to patients exhibiting severe renal dysfunction, hepatic impairment, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Retain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, animals, and other individuals.
Sitagliptin/Metformin combination therapy (like Sitaglo M Tablet) carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Its occurrence is heightened in individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms might encompass muscular aches or weakness, lightheadedness, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaglo M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a healthy diet and exercise regimen. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin works by suppressing DPP-4 enzyme activity, thus boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitaglo M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitaglo M Tablet constituents or inactive ingredients should not take this medication. This medicine is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitagliptin/Metformin tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also termed Metformin-associated lactic acidosis (MALA). While uncommon, this adverse reaction necessitates caution in patients with kidney impairment, the elderly, and heavy alcohol consumers. Symptoms might include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow pulse. If these occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitaglo M Tablet use can indeed lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications. Patients might experience symptoms such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, is recommended by some experts.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitagliptin and metformin, combined as Sitaglo M Tablet, treat type 2 diabetes mellitus. In adults, this medication improves blood sugar control when used with a healthy diet and regular physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin works by suppressing the DPP4 enzyme, thus boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitaglo M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitaglo M Tablet constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitaglo M Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia should prompt immediate discontinuation of Sitagliptin + Metformin and consultation with a physician.
Prolonged Sitaglo M Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as numbness and tingling in extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 is recommended by some experts at least annually.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
Sitaglo M Tablet
142
MRP 165
13% off